BMRN vs OLN · P/E 40, rev $2.85B vs rev $6.54B
Biomarin Pharmaceutical Inc (BMRN) versus Olin Corporation (OLN) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Olin Corporation (OLN) is a chemicals company listed on NYSE.
Latest reported BMRN revenue for 2024-12-31 was $2.85B. Net income was $426.9M. Revenue was up 18.0% from 2023-12-31 to 2024-12-31. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported OLN revenue for 2024-12-31 was $6.54B. Net income was $105.0M. Revenue was down 4.3% from 2023-12-31 to 2024-12-31. OLN currently screens at market cap $2.62B.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. OLN currently screens at market cap $2.62B.
Not investment advice. Open the BMRN and OLN stock pages for the full models.
Not investment advice.